MediSix Therapeutics Launches with USD$20M Series A Financing – GlobeNewswire (press release)
|
MediSix Therapeutics Launches with USD$20M Series A Financing
GlobeNewswire (press release) Ltd, MediSix is taking a novel approach to engineer chimeric antigen receptor (“CAR”) T-cells to target T-cell leukemia and lymphoma. The Company has an exclusive licensing agreement with the National University of Singapore (NUS), enabling it to … |
